Article in Clinical journal of the American Society of Nephrology : CJASN, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
David M CharytanDivision of Nephrology, Department of Medicine, New York University Grossman School of Medicine, New York, New York.ORCID 0000-0002-7695-3583
Alvin H MossDivision of Nephrology, West Virginia University School of Medicine, Morgantown, West Virginia.ORCID 0000-0002-1640-3336
Manar ShalakDivisions of Geriatrics and Palliative Medicine, West Virginia University School of Medicine, Morgantown, West Virginia.ORCID 0009-0007-2763-0036
Wenbo WuDivision of Nephrology, Department of Medicine, New York University Grossman School of Medicine, New York, New York.ORCID 0000-0002-7642-9773
Laura M DemberRenal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0000-0002-9735-7473
Jesse Y HsuRenal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0000-0002-1522-6534
Natalie KuzlaCenter for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Denise EssermanDepartment of Biostatistics, Yale School of Public Health, New Haven, Connecticut.ORCID 0000-0003-1326-9618
Sahir KalimDivision of Nephrology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-1746-5790
Paul L KimmelNational Institutes of Diabetes Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
Mark B LockwoodDepartment of Biobehavioral Nursing Science, University of Illinois Chicago College of Nursing, Chicago, Illinois.ORCID 0000-0003-2534-8583
Nobuyuki MiyawakiDivision of Nephrology, Department of Medicine, New York University Grossman School of Medicine, New York, New York.ORCID 0000-0003-1920-6052
Beth PellegrinoDivision of Nephrology, West Virginia University School of Medicine, Morgantown, West Virginia.ORCID 0000-0003-3688-9377
Patrick H PunDivision of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.ORCID 0000-0002-9896-8292
Rudy QamhiyehThe Berman Center, Hennepin Healthcare Research Institute, Minneapolis, Minnesota.ORCID 0009-0008-2745-6389
Jennifer SchererDivision of Nephrology, Department of Medicine, New York University Grossman School of Medicine, New York, New York.ORCID 0000-0003-4679-5673
Sarah SchraubenRenal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.ORCID 0000-0003-2557-5161
Daniel E WeinerDivision of Nephrology, Department of Medicine, Tufts Medical Center, Boston, Massachusetts.ORCID 0000-0002-8775-394
Rajnish MehrotraKidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.ORCID 0000-0003-2833-067
HOPE Consortium
Funding
UPENN Scientific and Data Research Center for the HOPE Consortium to Reduce Pain and Opioid Use in HemodialysisÃÂÃÂ U01DK123813 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DEMBER, LAURA M, FARRAR, JOHN T · 2019 to 2024
$6.6M
Randomized ESRD Trial COmparing CBT alone VERsus with buprenorphine (RECOVER)U01DK123786 · NIDDK · UNIVERSITY OF WASHINGTON · PI CUKOR, DANIEL, MEHROTRA, RAJNISH · 2019 to 2022
$3.4M
Pain Reduction and Opioid MedIcation Safety in ESRD (PROMISE) studyU01DK123812 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JHAMB, MANISHA, LIEBSCHUTZ, JANE M · 2019 to 2020
$3.1M
University of Illinois at Chicago Hemodialysis Opioid Prescription Effort (HOPE) Clinical CenterU01DK123787 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOORENBOS, ARDITH Z, FISCHER, MICHAEL J. · 2019 to 2020
$3.0M
Pain, Opioids, and ESRD risk reduction with Mindfulness and Buprenorphine (POEM-B): A 3-arm multi-site randomized trial in hemodialysis patientsU01DK123814 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHARYTAN, DAVID M, LEE, JOSHUA D · 2019 to 2019
$2.9M
Vanderbilt-West Virginia (VWV) Collaborative: A HOPE Consortium Clinical CenterU01DK123821 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI CAVANAUGH, KERRI · 2019 to 2019
$2.9M
The Hemodialysis Opioid Prescription Effort ConsortiumU01DK123816 · NIDDK · HENNEPIN HEALTHCARE RESEARCH INSTITUTE · PI BART, GAVIN, JOHANSEN, KIRSTEN L. · 2019 to 2019
$2.6M
Video-Telecare Collaborative Pain Management to Improve Function and Reduce Opioid Risk in Patients with End Stage Renal Disease Receiving HemodialysisU01DK123817 · NIDDK · YALE UNIVERSITY · PI BECKER, WILLIAM C, CROWLEY, SUSAN T · 2019 to 2019
$2.6M
Reducing Chronic Pain and Opioid Use in Hemodialysis PatientsU01DK123818 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KALIM, SAHIR, NIGWEKAR, SAGAR · 2019 to 2019
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Fall Risk in Maintenance Hemodialysis Patients: A Secondary Analysis of the HOPE Consortium Trial. · full record | OpenQuestion